Evaxion A/S
Biotechnology ResearchHovedstaden, Denmark51-200 Employees
Evaxion A/S is a biotechnology research company based in Hørsholm, Denmark, focused on applying artificial intelligence to immunology. Its AI-Immunology platform is used to decode the human immune system in order to develop novel immunotherapies and vaccines for cancer, bacterial infections, and viral diseases, including personalized cancer vaccines and preclinical infectious disease programs. The company operates in a clinical-stage and preclinical space, targeting unmet medical needs by offering approaches that aim to design targeted treatments and vaccines. Its activities position it within the TechBio segment, combining computational methods with a focus on immune-related therapies. In addition to its core pipelines, Evaxion has engaged in collaborations and activities such as presenting AI-based vaccine design concepts and pursuing partnerships, including with the Gates Foundation, as part of its ongoing research and development efforts.